Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | ZEN-3694 |
Trade Name | |
Synonyms | ZEN003694|BETi ZEN-3694|ZEN3694|ZEN 3694 |
Drug Descriptions |
ZEN-3694 is a pan BET inhibitor that suppresses AR signaling, which potentially inhibits tumor progression (Cancer Res 2016;76(14 Suppl):Abstract nr LB-207, PMID: 32694156). |
DrugClasses | BET Inhibitor (Pan) 32 |
CAS Registry Number | NA |
NCIT ID | C126805 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Binimetinib + ZEN-3694 | Binimetinib ZEN-3694 | 0 | 1 |
Cisplatin + Etoposide + ZEN-3694 | Cisplatin Etoposide ZEN-3694 | 0 | 1 |
Cisplatin + ZEN-3694 | Cisplatin ZEN-3694 | 0 | 0 |
Entinostat + ZEN-3694 | Entinostat ZEN-3694 | 0 | 1 |
Enzalutamide + Pembrolizumab + ZEN-3694 | Enzalutamide Pembrolizumab ZEN-3694 | 0 | 1 |
Enzalutamide + ZEN-3694 | Enzalutamide ZEN-3694 | 0 | 3 |
Ipilimumab + Nivolumab + ZEN-3694 | Ipilimumab Nivolumab ZEN-3694 | 0 | 1 |
Nab-paclitaxel + Pembrolizumab + ZEN-3694 | Nab-paclitaxel Pembrolizumab ZEN-3694 | 0 | 1 |
Nivolumab + ZEN-3694 | Nivolumab ZEN-3694 | 0 | 1 |
Talazoparib + ZEN-3694 | Talazoparib ZEN-3694 | 0 | 3 |
ZEN-3694 | ZEN-3694 | 0 | 2 |